Suppr超能文献

探索阿片类物质使用障碍治疗药物的生活体验:一项众包便利样本的定性研究

Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.

作者信息

Victor Grant, Kheibari A, Strickland J C

机构信息

School of Social Work, Rutgers University, 120 Albany St, New Brunswick, NJ, 08901, USA.

School of Social Work, Wayne State University, 5447 Woodward Ave, Detroit, MI, 48202, USA.

出版信息

Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10.1007/s10597-024-01345-9. Epub 2024 Sep 5.

Abstract

Given the effectiveness of medication for opioid use disorder (MOUD) and low engagement of treatment among people who use drugs (PWUD), it is important to better understand how to engage treatment clients with MOUD care. The current study aimed to achieve this goal by using qualitative methodology to characterize the MOUD treatment experiences. Participants (N = 52) were recruited for an online semi-structured interview. Qualitative analysis revealed varied treatment experiences, with the majority expressing irregular and intermittent MOUD treatment engagement. The therapeutic effects of MOUD in curbing withdrawal symptoms in conjunction with counseling services was frequently mentioned, as well as a preference for methadone maintenance treatment (MMT) to buprenorphine or naltrexone. Many participants described barriers to treatment and continuation of care, including failed drug screens for non-opioid drugs, perceived stigma, and physician-initiated discontinuation of treatment. The current study revealed that patients had favorable experiences with MOUD treatment, particularly when supplemented with counseling services.

摘要

鉴于药物治疗阿片类物质使用障碍(MOUD)的有效性以及吸毒者(PWUD)对治疗的低参与度,更好地了解如何让治疗客户接受MOUD护理非常重要。当前的研究旨在通过使用定性方法来描述MOUD治疗经历来实现这一目标。招募了参与者(N = 52)进行在线半结构化访谈。定性分析揭示了不同的治疗经历,大多数人表示MOUD治疗参与不规律且断断续续。经常提到MOUD在结合咨询服务抑制戒断症状方面的治疗效果,以及对美沙酮维持治疗(MMT)优于丁丙诺啡或纳曲酮的偏好。许多参与者描述了治疗和持续护理的障碍,包括非阿片类药物药物筛查失败、感知到的耻辱感以及医生发起的治疗中断。当前的研究表明,患者对MOUD治疗有良好的体验,特别是在辅以咨询服务时。

相似文献

1
Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample.
Community Ment Health J. 2025 Apr;61(3):411-419. doi: 10.1007/s10597-024-01345-9. Epub 2024 Sep 5.
2
Perceptions around medications for opioid use disorder among a diverse sample of U.S. adults.
J Subst Use Addict Treat. 2024 Aug;163:209361. doi: 10.1016/j.josat.2024.209361. Epub 2024 May 3.
3
College students' perceived knowledge of and perceived helpfulness of treatments for opioid use disorder at two American universities.
Am J Drug Alcohol Abuse. 2020 Sep 2;46(5):589-603. doi: 10.1080/00952990.2020.1757686. Epub 2020 Jun 16.
4
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Addict Sci Clin Pract. 2019 Oct 1;14(1):37. doi: 10.1186/s13722-019-0166-0.
5
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
J Subst Use Addict Treat. 2024 Jun;161:209248. doi: 10.1016/j.josat.2023.209248. Epub 2023 Dec 9.
6
Pregnancy Rates Among Women Treated with Medication for Opioid Use Disorder.
J Gen Intern Med. 2024 Jun;39(8):1342-1348. doi: 10.1007/s11606-024-08689-8. Epub 2024 Feb 29.
8
Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
J Addict Dis. 2021 Jan-Mar;39(1):37-45. doi: 10.1080/10550887.2020.1811456. Epub 2020 Aug 24.
9
Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
Drug Alcohol Depend. 2021 Apr 1;221:108649. doi: 10.1016/j.drugalcdep.2021.108649. Epub 2021 Feb 22.

本文引用的文献

1
Treatment for Opioid Use Disorder: Population Estimates - United States, 2022.
MMWR Morb Mortal Wkly Rep. 2024 Jun 27;73(25):567-574. doi: 10.15585/mmwr.mm7325a1.
2
Trends in Use of Medication to Treat Opioid Use Disorder During the COVID-19 Pandemic in 10 State Medicaid Programs.
JAMA Health Forum. 2023 Jun 2;4(6):e231422. doi: 10.1001/jamahealthforum.2023.1422.
3
State Policies Could Impede New Efforts to Increase Access to Medications for Opioid Use Disorder.
JAMA Health Forum. 2023 Mar 3;4(3):e230071. doi: 10.1001/jamahealthforum.2023.0071.
5
Changes in Buprenorphine Prescribing to Medicaid Beneficiaries During the First Year of the COVID-19 Pandemic.
JAMA Netw Open. 2022 Mar 1;5(3):e224058. doi: 10.1001/jamanetworkopen.2022.4058.
6
Peer recovery services for persons returning from prison: Pilot randomized clinical trial investigation of SUPPORT.
J Subst Abuse Treat. 2021 Jul;126:108339. doi: 10.1016/j.jsat.2021.108339. Epub 2021 Feb 27.
7
Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.
J Subst Abuse Treat. 2021 Jul;126:108329. doi: 10.1016/j.jsat.2021.108329. Epub 2021 Feb 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验